RxDoctor Payments Data

Brandi Weddle

Nurse Practitioner · Somerset, KYNPI 1033439609

Payments from drug & device makers

$2,028in general payments, 2019–2025

Across 105 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$277
  • Merck$263
  • Bayer$213
  • United Therapeutics Corporation$188
  • Pfizer$176
  • Novo Nordisk$170
  • plus $741 from 13 others

What the payments were for

  • Food & beverage$1,92895%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,028 in reported general payments places this provider in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$75,165
Medicare patients
469
Services billed
1,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban377$357,191
XareltoRivaroxaban250$257,693
EntrestoSacubitril/Valsartan193$196,922
BrilintaTicagrelor112$69,266
Repatha SureclickEvolocumab86$64,737
FarxigaDapagliflozin Propanediol72$53,922
MultaqDronedarone Hcl37$37,504
Ranolazine ErRanolazine326$33,045
Metoprolol Succinate893$8,788
Repatha PushtronexEvolocumab11$8,163
Rosuvastatin Calcium743$6,227
Isosorbide Mononitrate ErIsosorbide Mononitrate737$5,909
Diltiazem 24hr Er (Cd)Diltiazem Hcl211$4,680
Nifedipine ErNifedipine179$4,227
SotalolSotalol Hcl249$3,893

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$176$357,191377 claims
Johnson & JohnsonXarelto$154$257,693250 claims
NovartisEntresto$277$196,922193 claims
AstraZenecaBrilinta, Farxiga$167$123,188184 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Somerset

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →